Roivant Sciences Ltd. sell nvestor
Start price
30.09.23
/
50%
€10.50
Target price
30.09.24
€5.00
Performance (%)
-9.52%
End price
14.10.23
€9.50
Summary
This prediction ended on 14.10.23 with a price of €9.50. With a performance of -9.52%, the SELL prediction for Roivant Sciences Ltd. by nvestor was down slightly. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Roivant Sciences Ltd. | - | - |
| iShares Core DAX® | 2.831% | 1.236% |
| iShares Nasdaq 100 | 2.918% | 0.640% |
| iShares Nikkei 225® | 2.007% | -2.135% |
| iShares S&P 500 | 2.257% | 0.451% |
According to nvestor what are the pros and cons of Roivant Sciences Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Low dividend yield expected
Bad rating
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Few uniques
Dependend from some customers or products
Growths slower than the competition
Higher risks for its business
Significant cyclical dependencies
Business model of the past or high risk
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected
ROE lower than 10% per year
Little innovation
Little known brand
Sustainability is little important
high free float
Below average Marketposition
Comments by nvestor for this prediction
In the thread Roivant Sciences Ltd. diskutieren
In the thread Trading Roivant Sciences Ltd.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.